Search
for
Sort by
Research 31–60 of 616
- 73323 Androgenic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Repurposing of Drugs for Cardiometabolic Disorders: An Out and Out Cumulation
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Anabolic-Androgenic Steroids and Cardiometabolic Derangements
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Androgenetic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective
- A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries
- Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Comorbidities in Discoid Lupus: A Systematic Review and Meta-analysis of Prevalence and Association
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- 268 Male-pattern baldness and its association with coronary heart disease
- Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
- Assessment, diagnosis and treatment of a patient with hirsutism
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- From male PCOS to male endocrine-metabolic syndrome: a gender-neutral hypothesis
- Metabolic aging and cutaneous markers of metabolic syndrome: a narrative review
- POLYCYSTIC OVARY SYNDROME: EXPLORING THE ICEBERG OF A LIFELONG SYSTEMIC DISORDER